Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pegaspargase

D R Alfieri

    Pediatric Nursing
    |September 1, 1995
    PubMed
    Summary
    This summary is machine-generated.

    Pegaspargase effectively depletes L-asparagine in leukemia patients, reducing hypersensitivity reactions common with L-asparaginase. This modified enzyme offers improved pharmacokinetics for better chemotherapy outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Transdermal fentanyl.

    Pediatric nursing·1995
    Same journal

    Weight Management Clinic for the Treatment of a 14-Year-Old Female with Sudden Weight Gain.

    Pediatric nursing·2018
    Same journal

    Supporting Youth Aging Out of Foster Care.

    Pediatric nursing·2018
    Same journal

    Mentoring Practice and Mentoring Benefit 6: Equipping for Leadership and Leadership Readiness – An Overview and Application to Practice Using Mentoring Activities.

    Pediatric nursing·2018
    Same journal

    Children’s Exposure to Secondhand Smoke, Parental Nicotine Dependence, and Motivation to Quit Smoking.

    Pediatric nursing·2018
    Same journal

    Parental Knowledge about Urban Preschool Children’s Oral Health Risk.

    Pediatric nursing·2018
    Same journal

    Impacting Parental Vaccine Decision-Making.

    Pediatric nursing·2018
    See all related articles

    Area of Science:

    • Oncology
    • Biochemistry

    Background:

    • L-asparaginase is a key chemotherapy agent for acute lymphoblastic leukemia (ALL).
    • Hypersensitivity reactions frequently limit L-asparaginase treatment efficacy.
    • L-asparagine depletion is crucial for ALL treatment.

    Purpose of the Study:

    • To evaluate pegaspargase as an alternative to L-asparaginase in ALL treatment.
    • To highlight the benefits of pegaspargase over conventional L-asparaginase.

    Main Methods:

    • Comparative analysis of L-asparaginase and pegaspargase efficacy.
    • Assessment of hypersensitivity reaction incidence.
    • Pharmacokinetic profiling including half-life, solubility, and proteolysis resistance.

    Main Results:

    Related Experiment Videos

    • Pegaspargase achieves adequate L-asparagine depletion.
    • Pegaspargase demonstrates a reduced incidence of hypersensitivity reactions.
    • Pegaspargase exhibits a longer circulating half-life, increased solubility, and enhanced proteolysis resistance.

    Conclusions:

    • Pegaspargase is an effective alternative to L-asparaginase for ALL.
    • Pegaspargase offers improved patient tolerance and dosing convenience.
    • Pegaspargase represents a significant advancement in ALL chemotherapy.